Micro and Nano 3D investigation of complex gut alterations-dementia interplay
Authors:
F. Palermo,
N. Marrocco,
L. Dacomo,
E. Grisafi,
M. Musella,
V. Moresi,
A. Sanna,
L. Massimi,
I. Bukreeva,
O. Junemann,
I. Viola,
M. Eckermann,
P. Cloetens,
T. Weitkamp,
G. Gigli,
G. Logroscino,
N. Kerlero de Rosbo,
C. Balducci,
A. Cedola
Abstract:
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we…
▽ More
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we exploited X-ray Phase Contrast Tomography to provide an in-depth analysis of the link between the gut condition and AD, exploring gut anatomy and structure in murine models. We conducted a comprehensive analysis by comparing the outcomes in various mouse models of cognitive impairment, including AD, frail mice, and frontotemporal dementia (FTD) affected mice. We discovered an association between substantial changes in the gut structure and the presence of amyloid-beta (A\b{eta}) in the brain. We found that the most important gut alterations are related to A\b{eta} occurrence in the brain. In particular, we investigated the gut morphology, the distribution of enteric micro-processes and neurons in the ileum. Understanding the intricate interplay between gut condition and dementia may open new avenues for early AD diagnosis and treatment offering hope for a future where these diseases may be more effectively addressed.
△ Less
Submitted 24 April, 2024; v1 submitted 25 January, 2024;
originally announced January 2024.
Quantitative characterization of amyloid deposits in murine models of alzheimer disease by phase-contrast x-ray imaging
Authors:
A. Politano,
L. Massimi,
N. Pieroni1,
F. Palermo,
A. Sanna,
M. Fratini,
I. Bukreeva,
C. Balducci,
A. Cedola
Abstract:
Alzheimer's is a neurodegenerative disease that is the most common form of dementia, but there is still no definitive cure for this disease. The noninvasive X-ray Phase Contrast Tomography (XPCT) imaging technique was used to study brain tissues in mouse models of Alzheimer's disease, AP-PS1 and APP23. The XPCT technique enabled high-resolution imaging of brain tissues, distinguishing between diff…
▽ More
Alzheimer's is a neurodegenerative disease that is the most common form of dementia, but there is still no definitive cure for this disease. The noninvasive X-ray Phase Contrast Tomography (XPCT) imaging technique was used to study brain tissues in mouse models of Alzheimer's disease, AP-PS1 and APP23. The XPCT technique enabled high-resolution imaging of brain tissues, distinguishing between different brain structures, such as amyloid deposits and neuronal cells. In addition, the XPCT technique provided detailed information on the distribution and morphology of amyloid deposits in AP-PS1 and APP23 mice putting in evidence the differences between these two models. This work demonstrates the effectiveness of this technique in supporting Alzheimer's studies and evaluating new therapeutic strategies.
△ Less
Submitted 6 June, 2023;
originally announced June 2023.
